Robert W. Baird Has Lowered Expectations for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its price objective cut by research analysts at Robert W. Baird from $25.00 to $24.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s target price points to a potential upside of 22.59% from the company’s current price.

Other equities research analysts have also issued reports about the company. Royal Bank of Canada lifted their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a research report on Wednesday, January 15th. Wells Fargo & Company cut their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. Finally, StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Healthpeak Properties presently has an average rating of “Moderate Buy” and an average target price of $24.08.

Healthpeak Properties Price Performance

Shares of Healthpeak Properties stock opened at $19.58 on Tuesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.31. The business’s 50 day simple moving average is $20.54 and its two-hundred day simple moving average is $21.52. The stock has a market capitalization of $13.70 billion, a P/E ratio of 55.94, a price-to-earnings-growth ratio of 2.18 and a beta of 1.15. Healthpeak Properties has a one year low of $16.01 and a one year high of $23.26.

Institutional Investors Weigh In On Healthpeak Properties

Several hedge funds have recently added to or reduced their stakes in DOC. State Street Corp bought a new stake in Healthpeak Properties in the third quarter worth $1,093,576,000. Geode Capital Management LLC bought a new stake in Healthpeak Properties in the third quarter worth $403,898,000. Principal Financial Group Inc. boosted its holdings in Healthpeak Properties by 2,113.5% in the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after acquiring an additional 17,314,572 shares in the last quarter. Charles Schwab Investment Management Inc. bought a new stake in Healthpeak Properties in the third quarter worth $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Healthpeak Properties in the third quarter worth $175,697,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.